News

liver
Liver resection may lead to better outcomes than transarterial chemoembolization (TACE) for cirrhotic patients with resectable intermediate-stage hepatocellular carcinoma (HCC), according to a study published in Cancer Medicine. Although TACE is typically recommended for intermediate-stage HCC,… Read More
liver
A combined microsphere sizing strategy seemed technically feasible and had a promising toxicity profile and effectiveness measures, researchers reported. The study was prospective, single-center, and had a single arm consisting of 36 consecutive patients with hepatocellular carcinoma (HCC) who had… Read More
kidneys
Cryoablation of clinical T1 renal tumors is linked with poorer oncologic outcomes than partial nephrectomy, but patients who underwent cryoablation had lower rates of complications and better preservation of renal function, according to a study published in the Journal of Cancer. “For patients… Read More
lungs
Patients who underwent stereotactic ablative radiotherapy (SABR) for medically inoperable early-stage non-small cell lung cancer (NSCLC) had a pathologic complete response (pCR) rate that was lower than expected, according to a study published in JAMA Oncology. The researchers undertook the study… Read More
cancer cells
Patients with advanced biliary tract cancer (BTC) may potentially be treated with tremelimumab in combination with microwave ablation, according to a study published in Hepatology. The authors had previously seen promising results by combining tremelimumab with radiofrequency ablation for… Read More
liver cancer
Radioembolization with yttrium-90 (Y-90) microspheres may be an effective second-line therapy for patients with liver metastases from pancreatic adenocarcinoma, according to a study published in the Journal of Vascular and Interventional Radiology. The retrospective study involved 33 patients with… Read More
cancer cells
Stereotactic ablative radiation therapy (SABR) may help to improve outcomes for recurrent oligometastatic cancer and is accompanied by minimal acute and late grade 3 toxicity, according to a multicenter, phase 2 trial. “Oligometastatic disease has emerged as a potentially curable state in the… Read More
liver
Researchers have developed a prognostic score that can help to stratify candidates for transarterial chemoembolization (TACE), according to a study published in the Journal of Hepatology. “There lacks a prognostic model specifically developed for recommended or ideal TACE candidates with HCC (BCLC… Read More
liver
Patients with hepatocellular carcinoma (HCC) and gross vascular invasion (GVI) may have improved overall survival (OS) after being treated with dual modality radiation with external beam radiation therapy (EBRT) and transarterial radioembolization (TARE). Researchers reported their findings in the… Read More
liver
Results of a phase II trial suggest that image-guided high-dose-rate (HDR) brachytherapy (iBT) may lead to better outcomes than conventional transarterial embolization (cTACE) in treating unresectable hepatocellular carcinoma (HCC). The authors were interested in exploring the value of iBT in… Read More